Menu

Log In
Contact Us
About Us
Terms & Policies
Privacy Statement
Stock Market Mentor
Option Market Mentor
Crypto Market Mentor
Sign up
Log in

Search for:

Search for:

Menu

Trading Videos
- Fitz in Five
- Live Training Sessions
Trading Room
- Trading Room
Stocks
Options
- Option Trades List
- Video Archive
Crypto
- Crypto Video Library
- Join Crypto Market Mentor
Education
Video Archives
Store
Log in

Skip to content

Menu

Trading Videos
- Fitz in Five
- Live Training Sessions
Trading Room
- Trading Room
Stocks
Options
- Option Trades List
- Video Archive
Crypto
- Crypto Video Library
- Join Crypto Market Mentor
Education
Video Archives
Store
Log in

Skip to content

Strategy Session (April 06, 2016)

by DAN You must be logged in to view this content. Please log in Strategy Session

April 6, 2016 06:46 PM Tagged: video

Post navigation

← The DOJ killed AGN & PFE, right? Well, both are actually up today, but I want to look at the other major drug companies. Look at these charts of Pfizer (PFE), Merck (MRK) and Eli Lilly (LLY). (April 06, 2016)

3 Stocks I Saw on TV: HAL, BHI, AGN (April 06, 2016) →

Leave a Comment Cancel reply

You must be logged in to post a comment.

© 2025 Option Market Mentor All Rights Reserved. Reproduction without permission prohibited.
Investing involves substantial risk. No guarantee or other promise of performance or as to any results may be obtained from use of this information. The information provided herein is for educational purposes only and are only the ideas of the author with no guarantee of the outcome of such ideas. While past performance and/or references to potential future performance may be referenced or analyzed, past performance should not be considered indicative of future performance and references to potential future performance are only the opinion of the author and should not be relied upon without first conducting your own research and due diligence. No subscriber should make any investment decision without first conducting his or her own research and due diligence, including carefully reviewing the charts related to such security as well as the prospectus and any and all other public filings of the issuer of any security. The information provided is based upon and obtained from sources believed to be reliable. However, none of the information obtained or relied upon has been independently verified or otherwise investigated.